Zachary Sluzala

Mr. Zachary Sluzala

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2025 in Cells
Verified
Journal Article
Open access
PDF file
ZSZachary Sluzala
Zachary Sluzala
AHAngelina Hamati
Angelina Hamati
PFPatrice Fort
Patrice Fort
Heat shock proteins (HSPs) are essential molecular chaperones that protect cells by aiding in protein folding and preventing aggregation under stress conditions. Small heat shock proteins (sHSPs), which include members from HSPB1 to HSPB10, are particularly important for cellular stress responses. These proteins share a conserved α-crystallin domain (ACD) critical for their chaperone function, with flexible N- and C-terminal extensions that facilitate oligomer formation. Phosphorylation, a key post-translational modification (PTM), plays a dynamic role in regulating sHSP structure, oligomeric state, stability, and chaperone function. Unlike other PTMs such as deamidation, oxidation, and glycation—which are often linked to protein destabilization—phosphorylation generally induces structural transitions that enhance sHSP activity. Specifically, phosphorylation promotes the disaggregation of sHSP oligomers into smaller, more active complexes, thereby increasing their efficiency. This disaggregation mechanism is crucial for protecting cells from stress-induced damage, including apoptosis, inflammation, and other forms of cellular dysfunction. This review explores the role of phosphorylation in modulating the function of sHSPs, particularly HSPB1, HSPB4, and HSPB5, and discusses how these modifications influence their protective functions in cellular stress responses.

23 June 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
APAshutosh Phadte
Ashutosh Phadte
ZSZachary Sluzala
Zachary Sluzala
PFPatrice Fort
Patrice Fort
The chaperone and anti-apoptotic activity of α-crystallins (αA- and αB-) and their derivatives has received increasing attention due to their tremendous potential in preventing cell death. While originally known and described for their role in the lens, the upregulation of these proteins in cells and animal models of neurodegenerative diseases highlighted their involvement in adaptive protective responses to neurodegeneration associated stress. However, several studies also suggest that chronic neurodegenerative conditions are associated with progressive loss of function of these proteins. Thus, while external supplementation of α-crystallin shows promise, their potential as a protein-based therapeutic for the treatment of chronic neurodegenerative diseases remains ambiguous. The current review aims at assessing the current literature supporting the anti-apoptotic potential of αA- and αB-crystallins and its potential involvement in retinal neurodegenerative diseases. The review further extends into potentially modulating the chaperone and the anti-apoptotic function of α-crystallins and the use of such functionally enhanced proteins for promoting neuronal viability in retinal neurodegenerative disease.

4 December 2024 in Cells
Verified
Journal Article
Open access
PDF file
ZSZachary Sluzala
Zachary Sluzala
YSYang Shan
Yang Shan
LELynda Elghazi-Cras
Lynda Elghazi-Cras
ECEmilio Cardenas
Emilio Cardenas
AHAngelina Hamati
Angelina Hamati
PFPatrice Fort
Patrice Fort
HSPB4 and HSPB5 (α-crystallins) have shown increasing promise as neuroprotective agents, demonstrating several anti-apoptotic and protective roles in disorders such as multiple sclerosis and diabetic retinopathy. HSPs are highly regulated by post-translational modification, including deamidation, glycosylation, and phosphorylation. Among them, T148 phosphorylation has been shown to regulate the structural and functional characteristics of HSPB4 and underlie, in part, its neuroprotective capacity. We recently demonstrated that this phosphorylation is reduced in retinal tissues from patients with diabetic retinopathy, raising the question of its regulation during diseases. The kinase(s) responsible for regulating this phosphorylation, however, have yet to be identified. To this end, we employed a multi-tier strategy utilizing in vitro kinome profiling, bioinformatics, and chemoproteomics to predict and discover the kinases capable of phosphorylating T148. Several kinases were identified as being capable of specifically phosphorylating T148 in vitro, and further analysis highlighted mTORC2 as a particularly strong candidate. Altogether, our data demonstrate that the HSPB4-mTORC2 interaction is multi-faceted. Our data support the role of mTORC2 as a specific kinase phosphorylating HSPB4 at T148, but also provide evidence that the HSPB4 chaperone function further strengthens the interaction. This study addresses a critical gap in our understanding of the regulatory underpinnings of T148 phosphorylation-mediated neuroprotection.

2 March 2026 in Discoveries
Verified
Journal Article
Open access
ZSZachary Sluzala
Zachary Sluzala
KFKatrina E. Furth
Katrina E. Furth
Spina bifida is a neural tube defect (NTD) that arises when the neural tube fails to close properly during early development. This review focuses on myelomeningocele (MMC), the most common severe form of spina bifida, which often leads to motor and sensory impairments, including lower limb weakness or paralysis, as well as renal, urological, orthopedic, developmental, and psychosocial challenges. We explore the etiology, pathogenesis, prevention, diagnosis, and management of spina bifida, with a special emphasis on in-utero surgical repair. Over the past several decades, researchers and clinicians have made remarkable strides across all stages of care from prevention to postnatal outcomes. Widespread use of folic acid supplementation has significantly reduced the number of new cases. Advances in prenatal imaging and diagnostics now allow for earlier and more accurate detection, enabling timely intervention. In-utero surgical techniques continue to evolve, with innovative hybrid approaches that combine the strengths of open and minimally invasive methods. The momentum in this field shows no sign of slowing. Promising developments in stem cell therapy, biomaterials, robotic-assisted surgery, 3D printing, and enhanced imaging are redefining treatment goals in spina bifida. With each advance, clinicians gain better tools to improve outcomes for both mother and child, minimizing risks and maximizing long-term health and quality of life for both patients.

12 May 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
ZSZachary Sluzala
Zachary Sluzala
Small heat shock proteins (sHSPs) are chaperones which generally exhibit large, heterogenous, and polydisperse oligomeric assemblies. In part through their chaperone function, sHSPs exert protective effects in several contexts. Post-translational modifications (PTMs) of sHSPs, and in particular phosphorylation, are tightly linked to alterations in their structure and function. Specifically, we have previously shown that HSPB4 T148 phosphorylation, which is highly diminished in diabetic retinopathy, controls its protective capabilities in retinal neurons. Thus, we sought to characterize the structural and functional impacts of T148 phosphorylation on HSPB4, as well as the regulatory mechanisms underpinning this modification. In the introductory chapter of this dissertation, a review of sHSPs is presented. The roles of each protein domain and specific motifs, as well as of phosphorylation and other PTMs in regulating sHSP structure and function are first discussed, followed by an overview of disease associations, involvement in retinal neuroprotection, and regulation of sHSP phosphorylation. In chapter two, we have shown that T148 phosphorylation is associated with reduced stress-induced HSPB4 insolubility, altered oligomeric profile, improved chaperone function, and neuroprotective capacity in metabolic stress conditions. We have also identified paracrine protective roles of MGC-secreted HSPB4, and particularly of the functionally enhanced T148D HSPB4. In chapter three, we have identified several kinases, including mTORC2, which phosphorylate T148 in vitro. In addition to identifying mTORC2 as a bona fide T148-phosphorylating kinase, we have shown that its interaction with HSPB4 is strengthened by HSPB4 chaperone function. The findings presented in this dissertation further characterize T148 phosphorylation-mediated neuroprotection and the mechanistic underpinnings of this PTM. This fills several critical gaps in our knowledge of HSPB4 and lays the groundwork for further interrogation of its capabilities as a therapeutic agent.

20 April 2026 in Discoveries
Verified
Journal Article
Open access
ZSZachary Sluzala
Zachary Sluzala
Preliminary data for the Cellular Therapy for In Utero Repair of Myelomeningocele (CuRe) Trial have recently been published. These data showcase innovation in fetal surgery but introduce ethical questions regarding tissue sourcing. The CuRe Trial utilizes early gestational placental mesenchymal stromal/stem cells (PMSCs) in the repair technique. The ethical implications of this approach vary depending on whether they are sourced from miscarriage or elective abortion. The specific source of the PMSCs is unclear, but evidence suggesting that they might be sourced from elective abortion is presented, along with an overview of ethical implications if this is the case. Key questions considered include 1) whether research such as this is impacted by the recent decision by the National Institutes of Health (NIH) to cease funding of research using fetal tissue from elective abortion; 2) what ethical alternatives currently or may plausibly exist; and 3) whether scientific justifications exist for the use of tissue sourced from elective abortion over more ethical alternatives.